Catheter-related bloodstream infection caused by Mycobacterium brumae

Journal of Clinical Microbiology

Volumn 42, Issue 11, 2004, Pages 5429-5431

  Lee, Stephanie A ^a   Raad, Issam I ^a   Adachi, Javier A ^a   Han, Xiang Y ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFEPIME; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DEXAMETHASONE; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PACLITAXEL; RNA 16S; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; BREAST CANCER; CASE REPORT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; FEMALE; FEVER; GENE SEQUENCE; HUMAN; MASTECTOMY; MYCOBACTERIUM; MYCOBACTERIUM BRUMAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RASH; RNA SEQUENCE; SEQUENCE ANALYSIS; STEROID THERAPY;

BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; HUMANS; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM BRUMAE; POMACANTHUS MACULOSUS; UNCULTURED ACTINOMYCETE;

EID: 8644230859     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.11.5429-5431.2004     Document Type: Article

References (15)

1. Gaviria, J. M., P. J. Garcia, S. M. Garrido, L. Corey, and M. Boeckh. 2000. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol. Blood Marrow Transplant. 6:361-369.
2. Han, X. Y., A. S. Pham, J. J. Tarrand, P. K. Sood, and R. Luthra. 2002. Rapid and accurate identification of mycobacteria by sequencing hypervariable regions of the 16S ribosomal RNA gene. Am. J. Clin. Pathol. 118:796-801.
3. Han, X. Y., A. S. Pham, J. J. Tarrand, K. V. Rolston, L. O. Helsel, and P. N. Levett. 2002. Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp. nov. and Roseomonas gilardli subsp. rosea subsp. nov. Am. J. Clin. Pathol. 120:256-264.
4. Luquin, M., V. Ausina, V. Vincent-Levey-Frebault, M. A. Laneelle, F. Belda, M. Garcia-Barcelo, G. Prats, and M. Daffe. 1993. Mycobacterium brumae sp. nov., a rapidly growing, nonphotochromogenic mycobacterium. Int. J. Syst. Bacteriol. 43:405-413.
5. Mermel, L. A., B. M. Farr, R. J. Sherertz, I. I. Raad, N. O'Grady, J. S. Harris, and D. E. Craven. 2001. Guidelines for the management of intravascular catheter related infections. Clin. Infect. Dis. 32:1249-1272.
6. National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard M24-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Raad, I. I., S. Vartivarian, A. Khan, and G. P. Bodey. 1991. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev. Infect. Dis. 13:1120-1125.
8. Roy, V., and D. Weisdorf. 1997. Mycobacterial infections following bone marrow transplantation: a 20-year retrospective review. Bone Marrow Transplant. 19:467-470.
9. Tarrand, J. J., C. Guillot, M. Wenglar, J. Jackson, J. D. Lajeunesse, and K. V. Rolston. 1991. Clinical comparison of the resin-containing Bactec 26 plus and the Isolator 10 blood culturing systems. J. Clin. Microbiol. 29:2245-2249.
10. Turenne, C. Y., L. Tschetter, J. Wolfe, and A. Kabani. 2001. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J. Clin. Microbiol. 39:3637-3648.
11. Vincent, V., B. A. Brown-Elliott, K. C. Jost, and R. J. Wallace. 2003. Mycobacterium: phenotypic and genotypic identification, p. 560-584. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
12. Wallace, R. J., B. A. Brown, and G. O. Onyi. 1991. Susceptibility of Mycobacterium fortuitum biovar fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob. Agents Chemother. 35:773-775.
13. Wallace, R. J., L. C. Steele, A. Labidi, and V. A. Silcox. 1989. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. J. Infect. Dis. 160:281-288.
14. Woo, P. C. Y., H. W. Tsoi, K. W. Leung, P. N. L. Lum, A. S. P. Leung, C. H. Ma, K. M. Kam, and K. Y. Yeun. 2000. Identification of Mycobacterium neoaurum isolated from a neutropenic patient with catheter-related bacteremia by 16S rRNA sequencing. J. Clin. Microbiol. 38:3515-3517.
15. Yakrus, M. A., S. M. Hernandez, M. M. Floyd, D. Sikes, W. R. Butler, and B. Metchock. 2001. Comparison of methods for identification of Mycobacterium abscessus and M. chelonae isolates. J. Clin. Microbiol. 39:4103-4110.